Home > Food, Nutrition & Animal Feed > EPA/DHA (Omega 3) Ingredients Market

EPA/DHA (Omega 3) Ingredients Market Size by Product (EPA, DHA), By Source (Anchovy/Sardine Oil, High Concentrates, Medium Concentrates, Low Concentrates, Algae Oil, Tina oil, Cod Liver Oil, Salmon Oil, Krill Oil, Mehaden Oil and Application (Dietary Supplement, Functional Food, Pharmaceutical, Infant Formula, Pet & Animal Feed [Livestock, Aquaculture, Petfood]), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI118
  • Published Date: Nov 2022
  • Report Format: PDF

Industry Overview

EPA/DHA (Omega 3) Ingredients Market size was worth more than USD 2.5 billion in 2022 and is anticipated to record 6.5% CAGR from 2023-2032. Favorable government policies regarding dietary supplements are expected to complement the market expansion.
 

Get more details on this report - Request Free Sample PDF
 

Rising sales of dietary supplements are anticipated to fuel the demand for EPA-DHA (Omega 3) ingredients. In 2021, the global dietary supplements business was estimated at over USD 136 billion. EPA and DHA omega-3 fatty acids are extensively used in dietary supplements as they offer health benefits such as improved heart and brain health. These ingredients are also associated with weight management, joint health, and the maintenance of skin, eyesight, hair, and nails.
 

Stringent restrictions regulating the fishing sector and environmental policies regarding fish catches could restrain the EPA/DHA (Omega 3) ingredients market growth. Countries such as China, and Peru have imposed very strict rules on the number of fish catches in order to maintain an ecological balance. This will negatively affect fish oil production. On the contrary, favorable government policies regarding dietary supplements containing omega-3 ingredients will help boost product demand. For instance, the European Food Safety Authority (EFSA) permits the daily intake of omega-3 in restricted amounts to treat certain health conditions.
 

Growing concerns associated with preterm births will accelerate DHA consumption

EPA/DHA (Omega 3) ingredients market share from DHA segment is estimated to exceed USD 4.5 billion by 2032. Docosahexaenoic acid (DHA) omega-3 fatty acids are used in infant foods owing to their ability to aid in the development of the brain, eyes, and nervous system. They are also considered to help prevent the risk of early preterm births. For instance, according to an NICHD-funded clinical trial in May 2021, pregnant women who consumed 1,000 mg/day of DHA showcased a relatively lower preterm birth rate as compared to those who took 200 mg/day. Increasing R&D on DHA benefits on maternal and infant health will complement the segment statistics.
 

Rise in CVD mortality will increase consumer interest in anchovy/sardine oil for heart health

Get more details on this report - Request Free Sample PDF
 

Industry share from anchovy/sardine oils source is projected to witness over 8.5% CAGR between 2023-2032. Rise in the rate of mortality associated with heart disorders as a result of poor dietary habits and unhealthy lifestyles will fuel the consumption of anchovy and sardine oils as they are a rich source of omega-3 fatty acids including EPA and DHA. Anchovy oil helps lower blood pressure and reduce the risk of cardiovascular mortality. Cardiovascular diseases (CVDs) are a leading cause of death globally. According to the Centers for Disease Prevention & Control (CDC), one person dies every 34 seconds by CVD in the U.S.
 

Increasing omega-3 deficiency to accelerate the demand for omega-3 dietary supplements

Get more details on this report - Request Free Sample PDF
 

EPA/DHA (Omega 3) ingredients market share from dietary supplements is anticipated to expand at more than 6.5% CAGR through 2032. Growing consumer inclination towards high-quality dietary supplements to strengthen immunity and reduce the impact of a hectic lifestyle will positively influence the industry statistics. Dietary supplements containing EPA and DHA offer a wide range of health benefits. According to a study conducted by Pharmavite, in 2021, more than 68% of adults and 95% of children in the U.S fail to consume the required amounts of omega-3s as per the U.S. Dietary Guidelines. Omega-3 deficiency has a negative impact on vision and heart health and increases the risk of inflammation, thus propelling the demand EPA & DHA-rich dietary supplements.
 

High prevalence of dementia to augment APAC EPA/DHA (Omega 3) Ingredients market expansion

Get more details on this report - Request Free Sample PDF
 

Asia Pacific EPA/DHA (Omega 3) ingredients market size is poised to reach USD 1.5 billion by 2032. The presence of a constantly growing geriatric population suffering from age-related physical ailments will augment industry expansion. Omega-3 plays a significant nutritional role in maintaining heart health and brain health in the elderly population. Lack of EPA and DHA is linked with health conditions such as reduced immune function, memory loss, depression, Dementia, and a spectrum of other mental health problems. According to a study published in The Lancet Public Health, the number of people with dementia will surge by 197% in India, affecting nearly 152.8 million individuals by 2050. 
 

New product development efforts to boost EPA/DHA (Omega 3) ingredients industry development

Some of the leading companies in the global EPA/DHA (Omega 3) ingredients market include Nordic Naturals Inc, BASF SE, Koninklijke DSM N.V., Clover Corporation, Omega Protein, Copeinca ASA, Solutex, Epax Norway AS, Croda International Plc, Arista Industries Inc, GC Rieber, OLVEA, and Lysi. These companies are mainly focusing on the expansion of product portfolios.
 

Impact of COVID-19 pandemic on EPA/DHA (Omega 3) ingredients market trends

The COVID-19 pandemic had a positive impact on the EPA/DHA (Omega3) ingredients industry trends. Despite supply chain shortages and associated disruptions in demand and product prices, the pandemic fueled consumer interest in dietary supplements that are rich in Omega 3. To address the surging demand for Omega 3, new manufacturing capacities have been established in recent years along with extensive R&D on EPA and DHA. For instance, in September 2022, the Karolinska Institutet in Sweden conducted a study showcasing the efficacy of intravenous administration of Omega 3 to boost the immunity of COVID-19 patients.
 

EPA/DHA (Omega 3) Ingredients market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilo Tons and revenue in USD Million from 2018 to 2032 for the following segments:

By Product

  • EPA
  • DHA

By Source

  • Anchovy/Sardine Oils
  • High concentrates
  • Medium Concentrates
  • Low concentrates
  • Algae oil
  • Tuna oil
  • Cod liver oil
  • Salmon oil
  • Krill oil
  • Mehaden oil

By Application

  • Dietary Supplements
  • Functional Food
  • Pharmaceutical Food
  • Infant Food
  • Pet & Animal Feed 
    • Aquaculture
    • Livestock
    • Pet Food
  • Others

The above information is provided on a regional and country basis for the following:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Norway
    • Denmark
    • Turkey
    • Ireland
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Malaysia
    • Thailand
    • Indonesia
    • Vietnam
  • Latin America
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Equador
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa

 

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

Global market for EPA/DHA (Omega 3) ingredients was worth more than USD 2.5 billion in 2022 and is expected to record 6.5% CAGR from 2023-2032.
EPA/DHA (Omega 3) ingredients industry share from DHA segment is estimated to exceed USD 4.5 billion by 2032 due to its ability to prevent the risk of early preterm births.
Asia Pacific market size from EPA/DHA (Omega 3) ingredients is poised to reach USD 1.5 billion by the end of 2032 on account of the rising prevalence of mental health disorders such as dementia.
BASF SE, Clover Corporation, Omega Protein, Copeinca ASA, GC Rieber, Solutex, OLVEA, and Lysi are some of the leading manufacturers of EPA/DHA (Omega 3) ingredients worldwide.

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 418
  • Countries covered: 29
  • Pages: 344
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount